| Objective:To evaluate systemically the effect of dexmedetomidine on postoperative pain after laparoscopic cholecystectomy(LC).Methods:Two researchers independently searched Wanfang database,CNKI Chinese Journal Full-text Database,PubMed database,Embase database,Cochrane Library and CBM to extract the data according to inclusion and exclusion criteria strictly.During the process of data integration,the relevant data of pain score at 2-4h,6-8h,12h and 24h after LC,extubation time and complications were extracted,and the corresponding mean difference(MD),relative risk(RRs)and 95%Confidence Intervals(95%CI)were calculated.Results:Eighteen[3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20]trials with 1363 patients were included in this meta-analysis.(1)Patients receiving dexmedetomidine had lower pain scores at2-4h(SMD,-2.41;95%CI:-3.04-1.78;P<0.00001),6-8h(SMD,-1.63;95%CI:-2.39-0.88;P<0.0001),12h(SMD,-1.69;95%CI:-2.20-1.17;P<0.00001)and 24h(SMD,-1.33;95%CI:-1.88-0.78;P<0.00001)after LC.(2)The time of extubation after LC was longer in dexmedetomidine group than in control group(MD,5.33second,95%CI:1.609.05;P=0.005).(3)Dexmedetomidine could significantly reduce the incidence of postoperative nausea and vomiting([RR]=0.47;95%CI:0.290.77;P=0.003),shivering([RR]=0.43;95%CI:0.210.88;P=0.02),dysphoria([RR]=0.20;95%CI:0.110.40;P<0.00001)and increase the incidence of bradycardia([RR]=3.35;95%CI:1.666.75;P=0.0007)comparingwiththecontrolgroup.(4)Dexmedetomidine-treated patients required less rescue analgesia for intolerable pain([RR]=0.33;95%CI:0.230.46;P<000001).Conclusions:The fingdings indicate that dexmedetomidine could reduce postoperative pain after laparoscopic cholecystectomy.In addition,dexmedetomidine could significantly reduce the incidence of postoperative nausea and vomiting、shivering、dysphoria and increase the incidence of bradycardia. |